Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 6/2009

01-12-2009 | ORIGINAL ARTICLE

Long-term exposure of human proximal tubule cells to hydroxycobalamin[c-lactam] as a possible model to study renal disease in methylmalonic acidurias

Authors: S. W. Sauer, S. Opp, A. Haarmann, J. G. Okun, S. Kölker, M. A. Morath

Published in: Journal of Inherited Metabolic Disease | Issue 6/2009

Login to get access

Summary

Dysfunction of proximal tubules resulting in tubulointerstitial nephritis and chronic renal failure is a frequent long-term complication of methylmalonic acidurias. However, the underlying pathomechanisms have not yet been extensively studied owing to the lack of suitable in vitro and in vivo models. Application of hydroxycobalamin[c-lactam] has been shown to inhibit the metabolism of hydroxycobalamin and, thereby, to induce methylmalonic aciduria in rats, oligodendrocytes, and rat hepatocytes. Our study characterizes the biochemical and bioenergetic effects of long-term exposure of human proximal tubule cells to hydroxycobalamin[c-lactam], aiming to establish a novel in vitro model for the renal pathogenesis of methylmalonic acidurias. Incubation of human proximal tubule cells with hydroxycobalamin[c-lactam] and propionic acid resulted in a strong, time-dependent intra- and extracellular accumulation of methylmalonic acid. Bioenergetic studies of respiratory chain enzyme complexes revealed an increase of complex II–IV activity after 2 weeks and an increase of complex I and IV activity as well as a decrease of complex II and III activity after 3 weeks of incubation. In addition, human proximal tubule cells displayed reduced glutathione content after the exposure to hydroxycobalamin[c-lactam] and propionic acid.
Literature
go back to reference Brass EP (1993) Hydroxycobalamin[c-lactam] increases total coenzyme A content in primary culture hepatocytes by accelerating coenzyme A biosynthesis secondary to Acyl-CoA accumulation. J Nutr 123:1801–1807PubMed Brass EP (1993) Hydroxycobalamin[c-lactam] increases total coenzyme A content in primary culture hepatocytes by accelerating coenzyme A biosynthesis secondary to Acyl-CoA accumulation. J Nutr 123:1801–1807PubMed
go back to reference Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146:95–158CrossRefPubMed Burckhardt BC, Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146:95–158CrossRefPubMed
go back to reference Chandler RJ, Sloan J, Fu H et al (2007) Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet 8:64CrossRefPubMedPubMedCentral Chandler RJ, Sloan J, Fu H et al (2007) Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle. BMC Med Genet 8:64CrossRefPubMedPubMedCentral
go back to reference Cheema-Dhadli S, Leznoff CC, Halperin ML (1975) Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr Res 9:905–908PubMed Cheema-Dhadli S, Leznoff CC, Halperin ML (1975) Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr Res 9:905–908PubMed
go back to reference D’Angio CT, Dillon MJ, Leonard JV (1991) Renal tubular dysfunction in methylmalonic acidaemia. Eur J Pediatr 150:259–263CrossRefPubMed D’Angio CT, Dillon MJ, Leonard JV (1991) Renal tubular dysfunction in methylmalonic acidaemia. Eur J Pediatr 150:259–263CrossRefPubMed
go back to reference de Keyzer Y, Valayannopoulos V, Benoist JF et al (2009) Multiple OXPHOS deficiency in the liver, kidney, heart and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 66(1):91–95CrossRefPubMed de Keyzer Y, Valayannopoulos V, Benoist JF et al (2009) Multiple OXPHOS deficiency in the liver, kidney, heart and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 66(1):91–95CrossRefPubMed
go back to reference Fenton WA, Gravel RA, Rosenblatt (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds). The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 2165–2193 Fenton WA, Gravel RA, Rosenblatt (2001) Disorders of propionate and methylmalonate metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds). The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 2165–2193
go back to reference Halperin ML, Schiller CM, Fritz IB (1971) The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria: a possible explanation for hypoglycemia in methylmalonic aciduria. J Clin Invest 50:2276–2282CrossRefPubMedPubMedCentral Halperin ML, Schiller CM, Fritz IB (1971) The inhibition by methylmalonic acid of malate transport by the dicarboxylate carrier in rat liver mitochondria: a possible explanation for hypoglycemia in methylmalonic aciduria. J Clin Invest 50:2276–2282CrossRefPubMedPubMedCentral
go back to reference Hoffmann GF, Meier-Augenstein W, Stöckler S et al. (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 16:648–669CrossRefPubMed Hoffmann GF, Meier-Augenstein W, Stöckler S et al. (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 16:648–669CrossRefPubMed
go back to reference Hörster F, Baumgartner, Viardot C et al (2007) Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut−, cblA, cblB). Pediatr Res 62:225CrossRefPubMed Hörster F, Baumgartner, Viardot C et al (2007) Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut−, cblA, cblB). Pediatr Res 62:225CrossRefPubMed
go back to reference Kabe Y, Ohmori M, Shinouchi K et al (2006) Porphyrin accumulation in mitochondria is mediated by 2-oxoglutarate carrier. J Biol Chem 281:31729–31735CrossRefPubMed Kabe Y, Ohmori M, Shinouchi K et al (2006) Porphyrin accumulation in mitochondria is mediated by 2-oxoglutarate carrier. J Biol Chem 281:31729–31735CrossRefPubMed
go back to reference Kashtan CE, Abousedira M, Rozen S, Manivel JC, McCann M, Tuchman M (1998) Chronic administration of methylmalonic acid (MMA) to rats causes proteinuria and renal tubular injury (abstract). Pediatr Res 43:309ACrossRef Kashtan CE, Abousedira M, Rozen S, Manivel JC, McCann M, Tuchman M (1998) Chronic administration of methylmalonic acid (MMA) to rats causes proteinuria and renal tubular injury (abstract). Pediatr Res 43:309ACrossRef
go back to reference Kolhouse JF, Stabler SP, Allen RH (1993) Identification and perturbation of mutant human fibroblasts based on measurements of methylmalonic acid and total homocysteine in the culture media. Arch Biochem Biophys 303:355–360CrossRefPubMed Kolhouse JF, Stabler SP, Allen RH (1993) Identification and perturbation of mutant human fibroblasts based on measurements of methylmalonic acid and total homocysteine in the culture media. Arch Biochem Biophys 303:355–360CrossRefPubMed
go back to reference Kölker S, Schwab M, Horster F et al (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278:47388–47393CrossRefPubMed Kölker S, Schwab M, Horster F et al (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278:47388–47393CrossRefPubMed
go back to reference Krahenbuhl S, Ray DB, Stabler SP, Allen RH, Brass EP (1990) Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria. J Clin Invest 86:2054–2061CrossRefPubMedPubMedCentral Krahenbuhl S, Ray DB, Stabler SP, Allen RH, Brass EP (1990) Increased hepatic mitochondrial capacity in rats with hydroxy-cobalamin[c-lactam]-induced methylmalonic aciduria. J Clin Invest 86:2054–2061CrossRefPubMedPubMedCentral
go back to reference Krahenbuhl S, Chang M, Brass EP et al (1991) Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J Biol Chem 266:20998–21003PubMed Krahenbuhl S, Chang M, Brass EP et al (1991) Decreased activities of ubiquinol:ferricytochrome c oxidoreductase (complex III) and ferrocytochrome c:oxygen oxidoreductase (complex IV) in liver mitochondria from rats with hydroxycobalamin[c-lactam]-induced methylmalonic aciduria. J Biol Chem 266:20998–21003PubMed
go back to reference Ledley FD, Lumetta, Zoghbi HY et al (1988) Mapping of human methylmalonyl CoA mutase (MUT) locus on chromosome 6. Am J Hum Genet 42:839PubMedPubMedCentral Ledley FD, Lumetta, Zoghbi HY et al (1988) Mapping of human methylmalonyl CoA mutase (MUT) locus on chromosome 6. Am J Hum Genet 42:839PubMedPubMedCentral
go back to reference Mahoney MJ, Hart AC, Steen VD et al (1975) Methylmalonicacidemia: biochemical heterogeneity in defects of 5′-deoxyadenosylcobalamin synthesis. Proc Natl Acad Sci U S A 72:2799–2803CrossRefPubMedPubMedCentral Mahoney MJ, Hart AC, Steen VD et al (1975) Methylmalonicacidemia: biochemical heterogeneity in defects of 5′-deoxyadenosylcobalamin synthesis. Proc Natl Acad Sci U S A 72:2799–2803CrossRefPubMedPubMedCentral
go back to reference Mirandola SR, Melo DR, Schuck PF et al (2008) Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis 31:44–54CrossRefPubMed Mirandola SR, Melo DR, Schuck PF et al (2008) Methylmalonate inhibits succinate-supported oxygen consumption by interfering with mitochondrial succinate uptake. J Inherit Metab Dis 31:44–54CrossRefPubMed
go back to reference Morath MA, Okun JG, Müller IB et al (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria—A pathophysiological approach. J Inherit Metab Dis 31:35–43CrossRefPubMed Morath MA, Okun JG, Müller IB et al (2008) Neurodegeneration and chronic renal failure in methylmalonic aciduria—A pathophysiological approach. J Inherit Metab Dis 31:35–43CrossRefPubMed
go back to reference Oberholzer VG, Levin B, Burgess EA et al (1967) Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child 42:492CrossRefPubMedPubMedCentral Oberholzer VG, Levin B, Burgess EA et al (1967) Methylmalonic aciduria. An inborn error of metabolism leading to chronic metabolic acidosis. Arch Dis Child 42:492CrossRefPubMedPubMedCentral
go back to reference Okun JG, Horster F, Farkas LM et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674–14680CrossRefPubMed Okun JG, Horster F, Farkas LM et al (2002) Neurodegeneration in methylmalonic aciduria involves inhibition of complex II and the tricarboxylic acid cycle, and synergistically acting excitotoxicity. J Biol Chem 277:14674–14680CrossRefPubMed
go back to reference Peters HL, Nefedov M, Lee LW et al (2002) Molecular studies in mutase-deficient(MUT) methylmalonic aciduria: identification of five novel mutations. Hum Mutat 20:406CrossRefPubMed Peters HL, Nefedov M, Lee LW et al (2002) Molecular studies in mutase-deficient(MUT) methylmalonic aciduria: identification of five novel mutations. Hum Mutat 20:406CrossRefPubMed
go back to reference Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836CrossRefPubMed Sauer SW, Okun JG, Schwab MA et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem 280:21830–21836CrossRefPubMed
go back to reference Schwab MA, Sauer SW, Okun JG et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398:107CrossRefPubMedPubMedCentral Schwab MA, Sauer SW, Okun JG et al (2006) Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 398:107CrossRefPubMedPubMedCentral
go back to reference Sponne IE, Gaire D, Stabler SP et al (2000) Inhibition of vitamin B12 metabolism by OH-cobalamin c-lactam in rat oligodendrocytes in culture: a model for studying neuropathy due to vitamin B12 deficiency. Neurosci. Lett. 288:191–194CrossRefPubMed Sponne IE, Gaire D, Stabler SP et al (2000) Inhibition of vitamin B12 metabolism by OH-cobalamin c-lactam in rat oligodendrocytes in culture: a model for studying neuropathy due to vitamin B12 deficiency. Neurosci. Lett. 288:191–194CrossRefPubMed
Metadata
Title
Long-term exposure of human proximal tubule cells to hydroxycobalamin[c-lactam] as a possible model to study renal disease in methylmalonic acidurias
Authors
S. W. Sauer
S. Opp
A. Haarmann
J. G. Okun
S. Kölker
M. A. Morath
Publication date
01-12-2009
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 6/2009
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1197-6

Other articles of this Issue 6/2009

Journal of Inherited Metabolic Disease 6/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.